Page last updated: 2024-10-19

melatonin and Cryptogenic Fibrosing Alveolitis

melatonin has been researched along with Cryptogenic Fibrosing Alveolitis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hosseinzadeh, A2
Javad-Moosavi, SA2
Reiter, RJ2
Hemati, K1
Ghaznavi, H2
Mehrzadi, S2
Zhao, X1
Sun, J1
Su, W1
Shan, H2
Zhang, B1
Wang, Y1
Shabanova, A1
Liang, H1
Yarahmadi, R1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Pilot Placebo-controlled Randomized Double-blind Trial of Melatonin in Outpatients With COVID-19 Infection[NCT04784754]Phase 20 participants (Actual)Interventional2021-04-01Withdrawn (stopped due to lack of subject enrollment)
A Pilot Placebo-controlled Randomized Double-blind Trial of Melatonin in Outpatients With COVID-19 Infection[NCT04474483]Phase 28 participants (Actual)Interventional2020-11-06Terminated (stopped due to difficult recruitment and complete first visit in person during thne hight of tne pandemic and later not enough subjects)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for melatonin and Cryptogenic Fibrosing Alveolitis

ArticleYear
Idiopathic pulmonary fibrosis (IPF) signaling pathways and protective roles of melatonin.
    Life sciences, 2018, May-15, Volume: 201

    Topics: Animals; Antioxidants; Humans; Idiopathic Pulmonary Fibrosis; Melatonin; Protective Agents; Signal T

2018
Oxidative/nitrosative stress, autophagy and apoptosis as therapeutic targets of melatonin in idiopathic pulmonary fibrosis.
    Expert opinion on therapeutic targets, 2018, Volume: 22, Issue:12

    Topics: Animals; Antioxidants; Apoptosis; Autophagy; Fibroblasts; Humans; Idiopathic Pulmonary Fibrosis; Mel

2018

Other Studies

1 other study available for melatonin and Cryptogenic Fibrosing Alveolitis

ArticleYear
Melatonin Protects against Lung Fibrosis by Regulating the Hippo/YAP Pathway.
    International journal of molecular sciences, 2018, Apr-09, Volume: 19, Issue:4

    Topics: Adaptor Proteins, Signal Transducing; Animals; Bleomycin; Cell Cycle Proteins; Disease Models, Anima

2018
Melatonin Protects against Lung Fibrosis by Regulating the Hippo/YAP Pathway.
    International journal of molecular sciences, 2018, Apr-09, Volume: 19, Issue:4

    Topics: Adaptor Proteins, Signal Transducing; Animals; Bleomycin; Cell Cycle Proteins; Disease Models, Anima

2018
Melatonin Protects against Lung Fibrosis by Regulating the Hippo/YAP Pathway.
    International journal of molecular sciences, 2018, Apr-09, Volume: 19, Issue:4

    Topics: Adaptor Proteins, Signal Transducing; Animals; Bleomycin; Cell Cycle Proteins; Disease Models, Anima

2018
Melatonin Protects against Lung Fibrosis by Regulating the Hippo/YAP Pathway.
    International journal of molecular sciences, 2018, Apr-09, Volume: 19, Issue:4

    Topics: Adaptor Proteins, Signal Transducing; Animals; Bleomycin; Cell Cycle Proteins; Disease Models, Anima

2018